logo
The testosterone trap: Why your problem might not be ‘low T'

The testosterone trap: Why your problem might not be ‘low T'

CNNa day ago
Winding downFacebookTweetLink
Follow
Dr. Jamin Brahmbhatt is a urologist and robotic surgeon with Orlando Health and an assistant professor at the University of Central Florida's College of Medicine.
You're feeling unusually tired and sad, and your interest in sex has dropped off.
That's no fun. If you're a guy, you may be thinking you have low testosterone.
Wait a minute. Don't we all experience some or all of these symptoms at one time or another? After a late night out, a stressful workweek or even just a bad night's sleep, it's common to feel tired, irritable or unmotivated.
But I know my patients want to eliminate low testosterone as the source, so I often start with a survey called the Androgen Deficiency in the Aging Male, or ADAM, questionnaire. Take a minute to see how many 'yes' answers you collect.
Do you have a decrease in your libido, or sex drive?
Do you have a lack of energy?
Do you have a decrease in strength and/or endurance?
Have you lost height?
Have you noticed a decreased enjoyment of life?
Are you sad and/or grumpy?
Are your erections less strong?
Have you noticed a recent deterioration in your ability to play sports?
Are you falling asleep after dinner?
Has there been a recent deterioration in your work performance?
If you answered 'yes' to question 1 or 7, or to more than three questions overall, you might have low testosterone, according to this questionnaire.
Or maybe you don't. These questions and answers are the start of this journey, not the end. While these questions can be helpful, they're broad enough to describe common life experiences we all face.
As a urologist specializing in men's health, I often see patients convinced they have low testosterone based solely on these symptoms, only to find their testosterone levels are perfectly within range (more on those levels below).
Even as an expert in the field, I have also run to get my testosterone checked — only to realize my symptoms were due to poor sleep habits rather than a true hormone deficiency.
A quick note before we dive deeper: I understand this can be a sensitive topic. The information provided here isn't truth for every man. Many patients come to my clinic frustrated and seeking clear answers.
Even within the medical community, there's significant debate about how to diagnose and manage 'low T.' My intention isn't to discount or downplay your concerns but rather to provide perspective and education, and to help you make informed decisions with your health care provider.
Diagnosing low testosterone can be tricky, even for urologists like me. That said, a total testosterone level below 300 ng/dL (nanograms per deciliter) is recommended as the cutoff for diagnosing testosterone deficiency, according to the latest American Urological Association guidelines.
But here's the tricky part: Labs don't always agree on what they consider normal, leading to confusion for patients and medical professionals. Take two of the most popular labs in the United States — Quest Diagnostics and LabCorp — as examples. Quest lists a normal testosterone range of 250 to 1100 ng/dL, while LabCorp uses 264 to 916 ng/dL. This means a level of 260 ng/dL might be flagged as 'low' by one lab but 'normal' at another. That's why most American urologists rely on the AUA guidelines, bearing in mind that every patient's situation is different.
To ensure accuracy, guidelines recommend checking testosterone levels twice — on two separate mornings, ideally between 7 a.m. and 10 a.m. Why so early? Because that's when your fluctuating testosterone is at its peak, making it the best time to gauge your true levels. The first peak occurs in the morning, and the second peak (not as high as the morning) occurs in the afternoon, with your testosterone level gradually dropping by the end of the day. Lab companies also base their 'normal' reference ranges on the assumption that your testosterone tests are done during these specific morning hours.
Additionally, the clinical diagnosis of testosterone deficiency relies not only on lab numbers but also on the presentation of symptoms such as low energy, reduced libido, loss of muscle mass or mood changes.
When we start testosterone therapy, the goal is typically to raise testosterone levels into the range of about 450 to 600 ng/dL, which is considered the 'middle tertile' for most laboratory reference ranges. That middle third is the 'sweet spot' in which most men experience relief or resolution of their symptoms, without exceeding levels that could cause unwanted risks or side effects. It can take months to find the right and safe dose for a patient.
Further adding to our dilemma as doctors, testosterone sensitivity varies from man to man. This variation may relate to genetic factors, according to research, including the sensitivity of your testosterone receptors. That's why a man with a testosterone level of 400 ng/dL may feel great, while another at the same level may experience countless symptoms.
Currently, testing testosterone sensitivity isn't something readily available. The hope, however, is to someday have a routine test that helps us better personalize testosterone replacement therapy.
Diagnosing and treating low testosterone is still very much a work in progress, with ongoing debates among experts. However, other medical issues that mimic low testosterone symptoms are more straightforward, backed by strong research.
Many men whose testosterone lab results are completely normal still experience persistent symptoms. Often, these issues have more to do with lifestyle or other medical factors rather than testosterone itself.
In 2025, many medical professionals, including myself, have become more open to testosterone replacement therapy as newer research has disproven some of the significant risks previously feared, such as concerns over prostate cancer or cardiovascular disease.
Still, testosterone replacement isn't the right choice for everyone, and there could be other medical conditions that mimic the same symptoms that should be the primary focus of your (and your doctor's) investigation.
In my own experience, poor sleep has frequently been the reason behind feeling tired and irritable. Sleep is essential for hormone regulation, mood stability and overall health. Chronic sleep deprivation can lead to fatigue, mood swings, low libido and difficulty concentrating, according to the National Institutes of Health. Those are all symptoms that mimic what we see with low testosterone.
A common cause of poor sleep is obstructive sleep apnea, a condition where breathing repeatedly stops and starts when you're trying to get a good night's rest. Sleep apnea can dysregulate your hormonal balance and lower your testosterone levels. The use of continuous positive airway pressure, or CPAP, machines has been shown to improve sleep quality, improve testosterone and alleviate symptoms.
I started using an activity tracker 24/7, which quickly identified my own sleep issues. Eliminating late-afternoon caffeine and swapping evening screen time for reading before bed significantly boosted my sleep quality, energy levels and overall mood — without any hormone therapy. My own small changes led to big improvements.
Chronic stress may make you feel like your testosterone is low. Elevated cortisol, your body's primary stress hormone, can temporarily suppress testosterone production, causing symptoms identical to testosterone deficiency, especially reduced libido and fatigue.
Diet and exercise also play crucial roles. Studies have shown that testosterone levels in men have significantly declined over recent decades. Experts believe this decline is closely linked to rising obesity rates, chronic stress and increasingly sedentary lifestyles. Many of my own patients report dramatic improvements in energy, mood and libido simply by losing weight, eating healthier and staying physically active.
Several medical conditions can mimic symptoms attributed to low testosterone. Low thyroid or vitamin deficiencies (vitamin D or vitamin B12) can cause fatigue, mood changes and low libido. Diabetes or heart disease commonly cause fatigue and sexual dysfunction. Many patients initially thinking they have testosterone deficiency improve significantly after addressing these (and other) medical conditions without any need for hormonal treatment.
Another common scenario involves erectile dysfunction. Many patients mistakenly attribute their decreased libido or lack of sexual interest to low testosterone. In most cases, frustration and anxiety about sexual performance led to psychological withdrawal, decreasing sexual desire and confidence.
There is a small percentage of men whose erectile dysfunction genuinely stems from low testosterone levels. In these cases, testosterone replacement therapy might help. However, in my personal experience, replacing testosterone alone often leads to more frustration: Men may experience higher libido, yet still face difficulty achieving or maintaining an erection.
That's why it's usually better to treat ED directly — often with affordable generic medications like tadalafil or sildenafil — to restore sexual confidence and performance. These medications, once costing nearly $40 per pill, are now often as affordable as $40 for a three-month supply, providing a practical and reliable solution for most men.
The number of men receiving testosterone tests and prescriptions has nearly tripled in recent years, according to the 2024 American Urological Association guidelines.
Up to 25% of men starting testosterone therapy were never tested before starting treatment, the AUA noted. Nearly half never have their testosterone rechecked after initiating treatment. Up to a third of men receiving testosterone therapy don't meet the official clinical criteria for testosterone deficiency.
Meanwhile, many men who would benefit from testosterone replacement therapy remain untreated because of lingering concerns among health care providers about potential prostate cancer or cardiovascular risks — concerns not strongly supported by current evidence found in the AUA guidelines and recent research published in the New England Journal of Medicine. Additionally, men who skip routine screenings or simply don't feel comfortable openly discussing their symptoms also miss out on the treatment and relief they could experience.
This all feels like a 'chicken or egg' scenario: Will starting testosterone therapy motivate men to exercise more and manage their health better, or should we first address lifestyle and health issues before considering hormone therapy? These complexities highlight the importance of personalized conversations between you and your health care provider.
In my practice, I always focus first on lifestyle: Are you getting quality sleep? How high are your stress levels? Are you physically active? How healthy are your personal relationships? By tackling these areas first, many of my patients see noticeable improvement without falling into the testosterone trap.
Get inspired by a weekly roundup on living well, made simple. Sign up for CNN's Life, But Better newsletter for information and tools designed to improve your well-being.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

GDRX vs. HQY: Which Stock Is the Better Value Option?
GDRX vs. HQY: Which Stock Is the Better Value Option?

Yahoo

time24 minutes ago

  • Yahoo

GDRX vs. HQY: Which Stock Is the Better Value Option?

Investors with an interest in Medical Services stocks have likely encountered both GoodRx Holdings, Inc. (GDRX) and HealthEquity (HQY). But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out. Everyone has their own methods for finding great value opportunities, but our model includes pairing an impressive grade in the Value category of our Style Scores system with a strong Zacks Rank. The Zacks Rank is a proven strategy that targets companies with positive earnings estimate revision trends, while our Style Scores work to grade companies based on specific traits. Currently, GoodRx Holdings, Inc. has a Zacks Rank of #2 (Buy), while HealthEquity has a Zacks Rank of #3 (Hold). The Zacks Rank favors stocks that have recently seen positive revisions to their earnings estimates, so investors should rest assured that GDRX has an improving earnings outlook. But this is just one factor that value investors are interested in. Value investors also tend to look at a number of traditional, tried-and-true figures to help them find stocks that they believe are undervalued at their current share price levels. The Value category of the Style Scores system identifies undervalued companies by looking at a number of key metrics. These include the long-favored P/E ratio, P/S ratio, earnings yield, cash flow per share, and a variety of other fundamentals that help us determine a company's fair value. GDRX currently has a forward P/E ratio of 12.80, while HQY has a forward P/E of 27.57. We also note that GDRX has a PEG ratio of 1.15. This figure is similar to the commonly-used P/E ratio, with the PEG ratio also factoring in a company's expected earnings growth rate. HQY currently has a PEG ratio of 1.32. Another notable valuation metric for GDRX is its P/B ratio of 2.64. The P/B ratio pits a stock's market value against its book value, which is defined as total assets minus total liabilities. For comparison, HQY has a P/B of 4.2. These metrics, and several others, help GDRX earn a Value grade of B, while HQY has been given a Value grade of D. GDRX stands above HQY thanks to its solid earnings outlook, and based on these valuation figures, we also feel that GDRX is the superior value option right now. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report GoodRx Holdings, Inc. (GDRX) : Free Stock Analysis Report HealthEquity, Inc. (HQY) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Melden Sie sich an, um Ihr Portfolio aufzurufen.

Sliding vaccine rates hang over vote on CDC director nominee as US measles cases hit dangerous milestone
Sliding vaccine rates hang over vote on CDC director nominee as US measles cases hit dangerous milestone

CNN

time25 minutes ago

  • CNN

Sliding vaccine rates hang over vote on CDC director nominee as US measles cases hit dangerous milestone

The US Centers for Disease Control and Prevention on Wednesday tallied the highest number of US measles cases since the disease was declared eliminated a quarter-century ago, just as a key Senate committee split the vote to advance President Donald Trump's nominee to lead the public health agency. There have been more measles cases in the US this year than any other since the disease was declared eliminated a quarter-century ago, according to CDC data, with at least 1,288 confirmed cases. Just halfway through the year, the case tally has already surpassed the previous record from 2019, when there were a total of 1,274 cases. And it's well above the average of about 180 measles cases that have been reported each year since the disease was declared eliminated in the US in 2000. CNN reported this new milestone on Saturday using data from the Johns Hopkins University Center for Outbreak Response Innovation, which updates its numbers more frequently than the CDC. HHS has not responded to CNN's request for comment about the measles milestone. Childhood vaccine coverage has been declining in the US, and the vast majority of measles cases this year – more than 90% – have been in people who were unvaccinated or whose vaccination status was unknown, according to the CDC. When the measles case count reached its previous record in 2019 – during the first Trump administration – both the CDC director and the secretary of the US Department of Health and Human Services at the time released statements emphasizing the safety and effectiveness of the measles-mumps-rubella (MMR) vaccine and encouraging Americans to get vaccinated. However, almost six months into Trump's second term, the CDC still does not have a director and HHS Secretary Robert F. Kennedy Jr. has a long and complicated history with measles vaccines. HHS said in a statement Wednesday that the agency 'continues to support community efforts in dealing with the measles outbreaks' and 'CDC continues to provide technical assistance, laboratory support, and vaccines as requested.' The statement did not specifically address the new measles milestone, instead noting population-level case rates and echoing language that Kennedy has used about vaccines. 'CDC continues to recommend MMR vaccines as the best way to protect against measles. The decision to vaccinate is a personal one,' the statement said. 'People should consult with their healthcare provider to understand their options to get inoculated and should be informed about the potential risks and benefits associated with vaccines.' Concerns about vaccine skepticism were front and center Wednesday as members of the Senate Health, Education, Labor and Pensions Committee voted to advance President Donald Trump's nominee to lead the CDC, Dr. Susan Monarez, for a vote by the full Senate. Committee members voted 12-11 to move Monarez's nomination. All of the committee's Republicans backed the longtime immunologist and government scientist, who spoke in her confirmation hearing about restoring trust in the CDC and defended Kennedy's decision to replace the members of a federal panel of vaccine advisers. The vote puts Monarez one step closer to taking the helm at the public health agency, and she will now progress to a full Senate vote. HELP Chairman Sen. Bill Cassidy, a Louisiana Republican and a doctor, voted to advance Monarez's nomination but nodded to falling vaccine coverage and the ongoing measles outbreak. 'Dr. Monarez will work to modernize our data health systems, to improve public health coordination and response while protecting American sensitive health information,' Cassidy said. 'This is especially crucial as the nation combats reemerging public health threats like measles, which has taken three lives in the United States this year.' He continued: 'One that's not included but is tragic: A Canadian woman who was pregnant got exposed to measles and lost her child. [The ongoing outbreak has] hospitalized many more due to misinformation regarding the measles vaccine.' Cassidy publicly pressed Kennedy last month to delay a meeting of the health agency's new vaccine advisers — several of whom have expressed skepticism and safety concerns about long-approved immunizations — amid concerns about their biases. During Wednesday's meeting, Sen. Patty Murray, a Washington Democrat, called on the committee to hold a hearing about the ongoing measles outbreak and Kennedy's shakeup of vaccine oversight. 'I am concerned because this committee, it feels like, has all but abandoned its serious oversight of this crisis,' she said. 'We haven't had a hearing on the record-breaking number of measles outbreaks or a hearing on how the CDC vaccine panel is now stacked with people who are actually not vetted, and all the previous board members, every single one of them, was removed with no credible explanation.' There needs to be congressional oversight of these actions, Murray said after casting a vote against Monarez. 'I really do hope that Dr. Monarez will defy my expectations. I hope she will stand up for science and put public health first. But again, I hope I have hoped that for others, and here we are today,' she said. Some health experts have emphasized the importance of vaccination rates and their trepidation about precedents being set under Kennedy's leadership of HHS. 'It is no surprise that the most widespread measles outbreak affecting the United States in a generation has occurred under Secretary Kennedy's watch,' Dr. Richard Besser, president and CEO of the Robert Wood Johnson Foundation and former acting director of the CDC, said in a statement Wednesday. 'His decades-long campaign to discredit vaccines at every turn, which has continued unabated during his time as health secretary, directly contributes to the alarming decline in routine childhood vaccination rates in our country that is resulting in more frequent outbreaks of vaccine-preventable diseases,' he said. 'In addition, the dramatic funding cuts to public health will mean that small outbreaks will grow and spread.' Three people have died of measles in the US this year – two children in Texas and one adult in New Mexico, all of whom were unvaccinated – matching the total number of US measles deaths from the previous two and a half decades. 'I worry that even more children will be forced to pay with their lives or health because of Secretary Kennedy's malfeasance,' Besser said. 'As a pediatrician, I strongly encourage all parents to talk to their healthcare providers, listen to their local public health officials, and learn the facts about measles vaccines, which are incredibly effective and safe.' The MMR vaccine is highly effective. One dose offers 93% protection against measles, and two doses are 97% effective, according to the CDC. 'Vaccines work—full stop. They are one of the most powerful tools we have to protect patients, families and entire communities. We can prevent diseases through vaccines, but too many diseases that we once had under control are starting to reappear because people are choosing to delay or skip immunization,' Dr. Jennifer Brull, president of the American Academy of Family Physicians, said in a statement. 'There's a lot of confusion around vaccinations, but patients don't have to navigate this alone. Family physicians, pediatricians, pharmacists and other public health workers can help patients wade through all the information and cut through the noise,' she said. 'The bottom line is vaccines are safe, effective and save lives. It's critical that we continue to protect not just individual families, but the health of our entire nation.'

The diseases that could return as vaccination rates decline — and why you should care
The diseases that could return as vaccination rates decline — and why you should care

CNN

time26 minutes ago

  • CNN

The diseases that could return as vaccination rates decline — and why you should care

Vaccines Children's health Maternal health Women's healthFacebookTweetLink Follow Measles have surged to a record high, with more cases reported this year than any year since the disease was declared eliminated in the United States in 2000. This disappointing record comes amid falling childhood vaccination rates: Coverage against measles, mumps, rubella, chickenpox, polio and pertussis is declining in more than 30 states, according to data from the US Centers for Disease Control and Prevention. Some people may believe that if they're personally vaccinated, they have nothing to worry about. But is individual protection enough when contagious illnesses start multiplying? How will falling vaccination rates result in the return of previously eliminated diseases? Will only children be affected, or could adults see an impact as well? Who would be at highest risk if there is lower population-wide immunity? And what can be done to prevent this possibility? To get some answers, I spoke with CNN wellness expert Dr. Leana Wen. Wen is an emergency physician and clinical associate professor at George Washington University. She previously was Baltimore's health commissioner. CNN: Can falling vaccination rates result in the return of diseases that have been eliminated? Dr. Leana Wen: Yes. There are numerous examples around the world. Countries that were once polio-free have had polio outbreaks due to interruptions in childhood immunization programs caused by war and conflict. Measles outbreaks have occurred in countries where measles had been eliminated, due to falling vaccine coverage. This, in fact, is what we are seeing now in the US. In Texas, 753 measles cases have been confirmed since January. According to the Texas Department of State Health Services, 98 of these patients have been hospitalized, and two people, both children, have died. This outbreak is believed to have originated in communities with low vaccination rates. What could happen if childhood vaccination rates declined further? A recent study published in JAMA predicted that a 10% decline in measles-mumps-rubella (MMR) vaccine coverage could result in more than 11 million measles infections over 25 years. A 50% decline in routine childhood vaccinations could result in 51 million measles cases, 9.9 million rubella cases and 4.3 million polio cases. The projections also included the number of people affected by severe consequences of these diseases: As many as 10.3 million people in the US could be hospitalized, 159,200 could die, 5,400 could experience paralysis from polio, and 51,200 could have neurological consequences from measles. CNN: Is that only unvaccinated people? If someone is vaccinated, do they need to worry if others are unvaccinated? Wen: They should still worry for three main reasons. First, while many vaccinations provide excellent protection against disease, there is still a chance of breakthrough infections — meaning that the vaccine doesn't provide 100% protection. Two doses of the MMR vaccine are 97% protective against measles infection, which is an outstanding level of protection. But it's not 100%, so if someone is exposed to measles, there is still a chance they could become infected. However, vaccination substantially reduces the likelihood of infection and also of having severe disease if they were to become infected. The more disease there is in the community, the higher the likelihood of exposure and infection. Second, there may be some waning of vaccine effectiveness over time. For instance, according to the CDC, immunity to pertussis — also known as whooping cough — starts to wane after a few years following vaccination. Older adults who received childhood vaccinations many years ago may become susceptible if previously controlled childhood diseases make a comeback. Third, there are people who are unable to receive the benefit of vaccination directly themselves. Some people are unable to receive certain vaccines because of specific medical conditions. For instance, someone who has a weakened immune system may not be able to get the MMR vaccine because it contains a live, weakened form of the virus. Also, some people may have medical conditions that render vaccines less effective at protecting them. These individuals depend on the rest of society — those who can receive the vaccine — to do so and try to prevent these diseases from spreading. CNN: What about pregnant people? Are there also some vaccines they cannot get? Wen: This is another good point. Take rubella, or German measles. Pregnant individuals cannot receive the MMR vaccine because it contains live virus. But rubella can be especially dangerous during pregnancy. In addition to increasing the risk of miscarriage and stillbirth, rubella can lead to a condition called congenital rubella syndrome that can cause numerous birth defects including heart problems, brain damage, deafness, and lung, liver, eye and thyroid ailments. According to the World Health Organization, before the introduction of the vaccine, as many as 4 babies in every 1,000 live births were born with this condition. Rubella remains the leading cause of vaccine-preventable birth defects. Pregnant patients should not receive other live-attenuated vaccines either. Varicella, the vaccine against chickenpox, is another one of these vaccines. People should receive the vaccines before they are pregnant, ideally as part of their routine childhood immunizations. And other people can help to reduce disease in the community by getting vaccinated themselves. CNN: Who would be at highest risk if there is lower population-wide immunity? Wen: There are three groups I would be the most worried about. First are newborns who are too young to be vaccinated. They are also among the most medically fragile; something that is a mild cold for an older child or healthy adult could send them to the hospital. Second are immunocompromised people. This is a large group and includes patients receiving cancer treatments, transplant patients and individuals taking immunosuppressant medications. These individuals are more likely to become severely ill if exposed to disease. Vaccines may also not protect them as well, or they may be ineligible to receive certain vaccines as we discussed earlier. Third are the elderly. As we discussed many times in reference to Covid-19, these are individuals whose age and underlying medical conditions make them more susceptible to severe illness. That, in combination with possible waning immunity from certain vaccines, could put them at higher risk if there is more disease in the community because of lower vaccine coverage. CNN: What can be done to prevent this possibility? Wen: Everyone should speak with their primary care provider to verify that they are up to date on recommended vaccines. Parents with young children should do this with their family's pediatrician, and adults should also be sure to speak with their family physician or internist as well. The reason to do this is primarily to ensure that you are well-protected. If you are eligible for additional booster doses, you may consider getting them, or, if you are more susceptible to certain illnesses because you are not eligible for some vaccines, you should also know this and take precautions accordingly. There's another reason: The entire concept of population immunity depends on all of us doing our part to keep diseases at bay. That protects us — and others around us, including those who are especially vulnerable to severe illness and death.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store